市场调查报告书
商品编码
1219658
乳糖□全球市场规模、份额、行业趋势分析报告:按应用(饮料、药品和膳食补充剂)、区域展望和预测,2022-2028 年Global Lactase Market Size, Share & Industry Trends Analysis Report By Application (Food & Beverages and Pharmaceutical Products & Dietary Supplements), By Regional Outlook and Forecast, 2022 - 2028 |
在预测期内,全球乳糖□市场规模预计将以 6.5% 的复合年增长率增长,到 2028 年将达到 3.552 亿美元。
然而,最近发现一些人类社会发展出乳糖□持久性作为婴儿期后摄入乳製品和非人乳的适应。 据说爱尔兰人的乳糖□持久性异常高。 另一方面,地球上的大多数人都不同程度地存在乳糖□不耐症,并且是乳糖□不耐受症。 小肠中缺乏将乳糖分解成葡萄糖和半乳糖的乳糖□,是乳糖不耐症的原因。
乳糖不耐症可大致分为原发性、继发性、先天性和发育性。 原发性乳糖不耐症的发展是因为乳糖□的量随着年龄的增长而减少。 小肠疾病是继发性乳糖不耐受的主要原因。 感染、炎症性肠病、乳糜泻或其他疾病可能会造成此类损害。
COVID-19 影响分析
随着许多国家进入封锁状态,COVID-19 疫情影响了供应链。 由于全球经济和金融市场的不稳定,对化学中间体的需求也在下降。 因此,COVID-19 大流行带来的限制正在对乳糖□市场产生负面影响,尤其是随着工业设施的关闭和关闭。 大流行后客户偏好的变化已将业务需求转移到库存和清算技术上,从而停止了消费。
市场增长因素
儿童和成人乳糖不耐症增加
原发性乳糖不耐症是一种在婴儿期小肠完全形成之前发生的暂时性疾病。 经历继发性不耐受的成年人通常在小肠有消化问题。 此外,克罗恩病和胃肠炎等疾病会导致继发性乳糖不耐症。 根据美国国家生物技术信息中心 (NCBI) 的数据,世界上大多数人都容易受到乳糖□功能障碍的影响。 因此,已经开发出不含乳糖的牛奶和乳製品,以帮助乳糖不耐症患者避免胃肠道问题。
增加研究和开发以确定乳糖□提取和□利用的新鲜来源
乳糖□的来源多种多样。 现代研究和开发正在寻找包括细菌和真菌在内的新来源来提取□。 此外,通过使用□,可以提高饲料和食品的营养价值。 □还可以限制化学废物、水的使用和产品的生产,最大限度地减少对人类和环境的威胁。 由于食品和饮料行业需要多步製造工艺,因此真菌乳糖□在酸性 pH 值下稳定。
市场製约因素
纯素饮食和无奶替代品越来越受欢迎
植物奶的脂肪和糖含量极低,是脂肪摄入量很少的人的首选替代品。 专家建议儿童和对牛奶敏感或不耐受的人使用杏仁奶作为牛奶替代品。 然而,随着素食者人数的增加,植物性食品开始受到以前偏爱乳製品的消费者的欢迎。 此外,许多医生建议患有心脏病的患者采用植物性饮食,包括患有糖尿病和高血压等疾病的患者。 这一因素可能会限制预期期间的市场扩张。
来源观点
根据来源,乳糖□市场分为酵母、真菌和细菌。 2021 年,细菌部分在乳糖□市场取得了大幅增长。 长双歧桿菌、嗜酸乳桿菌和粪肠球菌这三种重要的细菌是乳糖□基因的来源。 它们在製造无乳糖产品的同时增加了□活性,并且是非致病性的。 因为它不致病,细菌乳糖□也用于人类营养和治疗。 越来越多地使用来自细菌的乳糖□是该领域发展的一个因素。
形态观
乳糖□市场按形式分为液态和干态。 液体部分将在 2021 年占据乳糖□市场最大的收入份额。 液态乳糖□可加速生物和化学过程,使其成为食品和饮料的理想选择。 此外,由于乳糖□是液体形式,它被稀释并且可以根据应用以较低的稀释率使用。 这样,可以立即食用乳製品的液滴的可用性是一个很大的优势,也是该领域扩展的一个因素。
应用展望
乳糖□市场按应用细分为食品和饮料以及药品和膳食补充剂。 2021 年,食品和饮料领域在乳糖□市场的收入份额最大。 有些人无法在小肠中製造乳糖□。 如果没有乳糖□,缺乏乳糖□的人就无法消化牛奶和乳製品中的天然双醣。 当向牛奶中添加乳糖□时,它会水解牛奶中存在的天然乳糖,使其更容易消化,同时保持温和的甜味。 □的这些特性扩大了它们在食品和饮料领域的用途,并正在推动该领域的发展。
区域展望
按区域划分,我们分析了四个区域的乳糖□市场:北美、欧洲、亚太地区和 LAMEA。 2021 年,北美市场在乳糖□市场的收入份额最大。 该地区有大量乳糖不耐症人口,因此呈现出北美乳糖□市场的增长潜力。 美国儿科学会 (AAP) 建议乳糖不耐症患者不要食用牛奶和其他乳製品,因为这些食物可为身体提供钙等必需营养素。
市场进入者采取的主要策略是产品发布和收购。 根据 Cardinal Matrix 中的分析,杜邦是乳糖□市场的领导者。 Koninklijke DSM N.V.、Kerry Group PLC 和 Novozymes A/S 等公司是乳糖□市场的领先创新者。
The Global Lactase Market size is expected to reach $355.2 Million by 2028, rising at a market growth of 6.5% CAGR during the forecast period.
The milk sugar lactose, also present in other dairy products, is broken down into the simple sugars glucose and galactose by the enzyme lactase. The need for lactase is anticipated to rise globally due to factors including expanding lactose-free demand and rising product research & developments in various fields of application like pharmaceutical, nutritional supplements, and baby nutrition. As a member of the galactosidase enzyme family, lactase hydrolyzes the disaccharide lactose into its component monomers of glucose and galactose.
The brush border layer of the developed enterocytes bordering the small intestine's villi is where lactase is primarily found. On chromosome 2, the LCT gene in humans encodes lactase. The ability of the lactase enzyme to continue functioning as an adult and break down lactose in milk is known as lactase persistence. After weaning, the enzyme's activity is significantly decreased in most mammals.
However, lactase persistence has lately developed in some human societies as an adaptation to the ingestion of dairy products and nonhuman milk after infancy. Irish people, in particular, have unusually high levels of lactase persistence. On the other hand, most people on the planet have varied degrees of lactose intolerance and are lactase non-persistent. Lack of the lactase enzyme in the small intestines, which breaks down lactose into glucose and galactose, is the cause of lactose intolerance.
Primary, secondary, congenital, and developmental are the four main categories of lactose intolerance. Primary lactose intolerance develops as people age because their lactase levels decrease. For the most part, the small intestinal damage is considered the main cause of secondary lactose intolerance. An infection, inflammatory bowel disease, celiac disease, or other illnesses may be accountable for such damage.
COVID-19 Impact Analysis
The COVID-19 outbreak has affected the supply chain due to the lockdown in many nations. Additionally, the outbreak decreased demand for chemical intermediates because of the unpredictability of the world economy and financial markets. Therefore, the constraints brought on by the COVID-19 pandemic have negatively impacted the lactase market, especially by the lockdowns and the closure of industrial facilities. Due to post-pandemic client preference changes, business requirements have transitioned to stock organization and liquidation techniques, with consumption at a stop.
Market Growth Factors
Increasing lactose intolerance in children and adults
Primary lactose intolerance is a transient condition that develops in early infants before the small intestine is fully formed. Adults who experience secondary intolerance typically have gastrointestinal problems in the small intestine. In addition, conditions like Crohn's disease or gastroenteritis can cause secondary lactose intolerance. According to the National Center for Biotechnology Information (NCBI), most of the world's population is susceptible to lactase insufficiency. As a result, the development of lactose-free milk and dairy products has increased, aiding those lactose intolerant in avoiding gastrointestinal issues.
Increased investigation and development to identify fresh sources for lactase extraction and enzyme use
The lactase enzyme is obtained from a variety of sources. To extract the enzyme, novel sources, including bacteria and fungi, are sought after by contemporary research and development. Additionally, the nutritional content of feed and food items is increased by applying enzymes. Enzymes also limit chemical waste, water use, and by-product production, posing minimal threats to people and the environment. Given that the food and beverage sector must go through several production processes, lactase enzymes derived from fungal sources have an acidic pH and are stable.
Market Restraining Factors
Increasing popularity of vegan diets and dairy-free alternatives
Due to its minimal fat and sugar content, plant-based milks are also a well-liked replacement for those who consume little to no fat. Experts suggest using almond milk as a workable replacement of milk for children and anyone with milk sensitivities or intolerances. However, as more individuals adopt a vegan lifestyle, plant-based foods are becoming more popular with consumers who previously preferred dairy products. Additionally, many doctors recommend plant-based diets for patients with cardiac problems, including those who also have diabetes, high blood pressure, and other illnesses. This factor can limit market expansion during the anticipated period.
Source Outlook
Based on source, the lactase market is categorized into yeast, fungi, and bacteria. The bacteria segment procured a considerable growth rate in the lactase market in 2021. Three important bacteria, Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis, are the origins of the lactase gene. These have increased enzymatic activity while producing lactose-free products and are non-pathogenic. Since they are not pathogens, lactase enzyme derived from bacteria finds use in human nutrition and for therapeutic purposes. The growing use bacteria sourced lactase is responsible for the growth of the segment.
Form Outlook
On the basis of form, the lactase market is divided into liquid and dry. The liquid segment acquired the largest revenue share in the lactase market in 2021. Since liquid lactase quickens biological and chemical processes, it is perfect for food and beverages. In addition, the lactase enzyme is diluted because it is in a liquid form and can potentially be used at lower dilutions, depending on the application. The availability of lactase liquid drops that enable people to consume dairy rather immediately is the main benefit of this form, and as such is accountable for the segment's expansion.
Application Outlook
Based on application, the lactase market is segmented into food & beverages and pharmaceutical products & dietary supplements. The food and beverages segment witnessed the maximum revenue share in the lactase market in 2021. Some individuals are unable to manufacture the lactase enzyme in the small intestines. People with lactase deficiencies cannot digest the natural disaccharide available in milk and milk products without it. When lactase is added to milk, the naturally occurring lactose in the milk is hydrolyzed, leaving it mildly sweet yet digestible. This characteristic of the enzyme broadens its use in the food and beverage sector and thus boosts the segment's growth.
Regional Outlook
On the basis of region, the lactase market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the maximum revenue share in the lactase market in 2021. The region's large population of lactose intolerant people presents a growth potential for the North American lactase market. The American Academy of Pediatrics (AAP) advises against encouraging persons who have lactose intolerance to consume milk or any other dairy product because these foods give the body essential nutrients like calcium.
The major strategies followed by the market participants are Product Launches and Acquisitions. Based on the Analysis presented in the Cardinal matrix; DuPont de Nemours, Inc. is the forerunner in the Lactase Market. Companies such as Koninklijke DSM N.V., Kerry Group PLC, Novozymes A/S are some of the key innovators in Lactase Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kerry Group PLC, Koninklijke DSM N.V., DuPont de Nemours, Inc., Novozymes A/S (Novo Holdings A/S), Chr. Hansen Holding A/S, Advanced Enzyme Technologies Limited, Oenon Holdings, Inc., Mitushi Biopharma, Natural Factors, and Amano Enzyme, Inc.
Recent Strategies Deployed in Lactase Market
Acquisitions and Mergers:
Feb-2022: Kerry completed the acquisition of two biotechnology companies, C-LEcta, a biotechnology innovation company, and Enmex which is an enzyme manufacturer. This acquisition would enhance the company's fermentation and enzyme capabilities.
Oct-2021: Royal DSM, completed the acquisition of First Choice Ingredients, a leading supplier of dairy-based savory flavorings. With this acquisition, DSM would strengthen the growth of First Choice Ingredients by delivering their products outside the US to serve the worldwide customer base. Moreover, DSM would integrate First Choice Ingredients' solutions into DSM's offering to deal with taste, texture, and health for Food & Beverage customers.
Nov-2020: Kerry completed the acquisition of Canadian company Bio-K Plus International, a probiotic company with a range of clinically supported probiotic beverage and supplement applications. This acquisition would broaden Kerry's current suite of probiotics.
Jun-2020: Novozymes completed the acquisition of PrecisionBiotics Group Limited, a healthcare company. This acquisition would focus on human health to make growth in Novozymes' business.
Product Launches and Expansions:
Nov-2020: Royal DSM unveiled its new Maxilact® Super lactase enzyme. With this launch, Royal DSM would aim to develop DSM's offering of Maxilact lactases which would allow dairy manufacturers to build clean tasting lactose-free and sugar-reduced dairy.
Nov-2020: Chr. Hansen announced the launch of next-generation Premium cultures YoFlex® Premium and nu-trish® that would produce a healthy high-textured yogurt, reducing the requirement for added ingredients.
Oct-2020: Novozymes and Firmenich, a privately owned perfume and taste company unveiled their mutually developed natural sugar reduction solution TasteGEM SWL, a sugar reduction solution, with Saphera lactase, a lactase enzyme. Combining both TasteGEM SWL with Saphera lactase, this technology would reduce sugar by up to 50% present in yogurt and other dairy products without the usage of sweeteners.
Geographical Expansions:
May-2022: Kerry Group expanded its geographical footprint by opening an advanced taste manufacturing facility in Africa. Based in KwaZulu-Natal, South Africa, this facility would provide aid in producing sustainable nutrition solutions to meet the demands of consumers across the African continent.
Jan-2022: Kerry Group expanded its business to Jeddah, Saudi Arabia, the company's largest plant in the Middle East, North Africa, and Turkey region. This plant would be utilized in the production of sustainable food ingredients to distribute them all over the Middle East.
Partnerships, Collaborations and Agreements:
Feb-2021: Kerry and Pharma Foods International Co. Ltd. (PFI), a functional food ingredient development and sales company signed a partnership that would develop, apply and sell global joint health ingredient technology for functional foods & beverages and dietary supplements to offer it to Kerry's global customers.
Market Segments covered in the Report:
By Application
By Source
By Form
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures